Your session is about to expire
← Back to Search
FAZA PET-MRI for Pancreatic Cancer
N/A
Recruiting
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants with histologically confirmed new diagnosis of unresectable, non-metastatic, LAPAC as assessed by the multidisciplinary tumor board based on pre-RT imaging and clinical assessment, and are amenable to SBRT
Patients who received prior systemic therapy for unresectable LAPAC and still have localized unresectable LAPAC amenable to SBRT
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2.5 years
Awards & highlights
Study Summary
This trial will investigate whether FAZA PET-MRI can help doctors measure hypoxia in patients with unresectable, non-metastatic, locally advanced un-resectable pancreatic adenocarcinoma.
Who is the study for?
This trial is for adults over 18 with non-metastatic, locally advanced pancreatic cancer that can't be surgically removed but hasn't spread elsewhere. They should have had prior therapy and still qualify for stereotactic body radiation therapy (SBRT). Pregnant women or those with previous upper abdomen radiation, other active cancers, MRI contraindications, or serious health issues are excluded.Check my eligibility
What is being tested?
The study tests FAZA-PET combined with MRI to measure oxygen levels in tumors of up to 20 patients before and after standard radiation treatment. FAZA is a new type of PET scan tracer. The goal is to see how well this imaging technique works in assessing tumor hypoxia in pancreatic cancer.See study design
What are the potential side effects?
Since the intervention involves diagnostic imaging rather than medication, side effects are minimal but may include discomfort from the procedure itself or reactions related to contrast agents used during scans if applicable.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My pancreatic cancer is new, cannot be surgically removed, but can be treated with SBRT.
Select...
I've had treatment for inoperable pancreatic cancer that's still localized and treatable with SBRT.
Select...
I have pancreatic cancer that was once possibly removable but now cannot be surgically removed after treatment.
Select...
I am 18 years old or older.
Select...
I have been recently diagnosed with a specific type of pancreatic cancer that might be operable.
Select...
I can take care of myself but might not be able to do heavy physical work.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2.5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2.5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Tumor Hypoxia
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,472 Previous Clinical Trials
484,984 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My pancreatic cancer is new, cannot be surgically removed, but can be treated with SBRT.I've had treatment for inoperable pancreatic cancer that's still localized and treatable with SBRT.Women who can have babies need to have a test that shows they are not pregnant before getting the PET-MR imaging.I have another cancer that is getting worse or was treated in the last 3 years.I do not have any severe illnesses or social situations that would stop me from following the study's requirements.You can receive treatment using the integrated magnet resonance linear accelerator (MRL).You are not allowed to have an MRI scan based on the rules of the hospital.I have pancreatic cancer that was once possibly removable but now cannot be surgically removed after treatment.You are expected to live for at least 6 more months.I am 18 years old or older.I have been recently diagnosed with a specific type of pancreatic cancer that might be operable.I can take care of myself but might not be able to do heavy physical work.My pancreatic cancer is in the early stages and can be surgically removed, or it has spread to distant parts of my body.I have had radiation therapy to my upper abdomen before.You are taking any other experimental drugs at the same time.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment still ongoing for this clinical investigation?
"Affirmative. According to information on clinicaltrials.gov, this research study is still recruiting participants as of today's date. It was uploaded on May 18th 2021 and has since been updated for the last time on June 5th 2022. The trial requires 20 volunteers from 1 medical facility."
Answered by AI
How many volunteers are eligible for participation in this trial?
"Affirmative. Clinicaltrials.gov indicates that this experiment, originally shared on May 18th 2021, is in need of volunteers. 20 individuals are currently required to be recruited from one medical site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger